Home
| Log in or Sign Up for full access
| Tracked Organizations
| Recent Tracked Activities
Recent Activities
Activities between Nov. 15, 2024, 7:49 p.m. and Nov. 22, 2024, 7:49 p.m.
in: Pennsylvania (United States).
Click on a document link to see the original source document.
Click on the name of an organization to see more organization linkages and timelines.
Document Date: Nov. 18, 2024, 2:30 p.m. / Source: PR Newswire
Activity Class: CorporateFinanceActivity
/ Type: Investment
Investor:
- L Catterton
/ Industry: Consumer Services, Fashion And Apparel and 5 more
Target:
- WeVets
/ Industry: Veterinary Industry
Document Extract: L Catterton Latin America Makes Strategic Investment in WeVets.
Document Source: https://www.prnewswire.com/news-releases/l-catterton-latin-america-makes-strategic-investment-in-wevets-302308545.html
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 9:26 p.m. / Source: Business Wire
Activity Class: CorporateFinanceActivity
/ Type: Acquisition
/ Region: Pennsylvania
Buyer:
- Pennsylvania American Water
/ Industry: Electric Utility Business, Underground Utility Locating And Damage Prevention Service Provider and 1 more
Target:
Document Extract: Pennsylvania American Water Completes Acquisition of Farmington Township Water and Wastewater Systems and Signs Agreement to Acquire Corner Water Supply and Service Corporation.
Document Source: https://www.businesswire.com/news/home/20241121779118/en/Pennsylvania-American-Water-Completes-Acquisition-of-Farmington-Township-Water-and-Wastewater-Systems-and-Signs-Agreement-to-Acquire-Corner-Water-Supply-and-Service-Corporation
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 9:26 p.m. / Source: Business Wire
Activity Class: CorporateFinanceActivity
/ Type: Acquisition
/ Region: Pennsylvania
Vendor:
Buyer:
- Pennsylvania American Water
/ Industry: Electric Utility Business, Underground Utility Locating And Damage Prevention Service Provider and 1 more
Participant:
- Pennsylvania American Water
/ Industry: Electric Utility Business, Underground Utility Locating And Damage Prevention Service Provider and 1 more
Target:
Document Extract: Pennsylvania American Water, a subsidiary of American Water (NYSE: AWK) , completed its acquisition of the Farmington Township water and wastewater system in Clarion County.
Document Source: https://www.businesswire.com/news/home/20241121779118/en/Pennsylvania-American-Water-Completes-Acquisition-of-Farmington-Township-Water-and-Wastewater-Systems-and-Signs-Agreement-to-Acquire-Corner-Water-Supply-and-Service-Corporation
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 3 p.m. / Source: prweb
Activity Class: LocationActivity
/ Type: Added
Location_Added_By:
Location:
Document Extract: Layne's Chicken Fingers Announces New Benton, Arkansas, Location Opening in December.
Document Source: https://www.prweb.com/releases/laynes-chicken-fingers-announces-new-benton-arkansas-location-opening-in-december-302308200.html
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 2 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
Partnership:
- SEI
/ Industry: Asset And Wealth Management, Asset Management Services and 7 more
- SEI
/ Industry: Asset And Wealth Management, Asset Management Services and 7 more
- Front Street Capital Management
/ Industry: Wealth Planning And Investment Advisory Firm
Document Extract: Michele Blood, Co-Founder and Chief Operating Officer at Front Street, summarized the firm's reasons for choosing SEI as its custodian and technology provider: " SEI's technology and advisor services capabilities are immensely important for us to provide more effective, efficient, and personal interactions and information for our growing client base, and SEI's commitment to supporting our distinctive investing activities, while continually enhancing their platform's capabilities, provided us the comfort to make the switch. SEI embodies our criteria for enduring, successful businesses, and that is also a key differentiator for us ." Highlighting the benefits of the strategic partnership, Gabriel Garcia, Head of RIA Client Strategy and Experience for SEI's Advisor business, said: " In today's landscape, tight integration across technology and operations matters-particularly when it comes to efficiently running a business while providing a connected and collaborative experience for advisors and investors.
Document Source: https://www.prnewswire.com/news-releases/front-street-capital-management-selects-sei-for-custody-and-advisor-technology-302312057.html
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 2 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: Oaks
Partnership:
- SEI
/ Industry: Asset And Wealth Management, Asset Management Services and 7 more
- SEI
/ Industry: Asset And Wealth Management, Asset Management Services and 7 more
Awarded:
Document Extract: Front Street Capital Management Selects SEI for Custody and Advisor Technology. Integrated Custody and Technology Solution Powers Connected Experience and Business Growth. OAKS, Pa., Nov. 21, 2024 /PRNewswire/ - SEI® (NASDAQ: SEIC) today announced that Front Street Capital Management (Front Street) has selected SEI for custody and technology solutions, embracing a tightly integrated, single infrastructure that provides an end-to-end experience across every aspect of an advisor's business, including a dedicated service and relationship management model. Front Street is moving more than $ 600 million in assets under management to SEI. The Montana - based registered investment advisor invests client capital exclusively in purpose-driven companies that demonstrate ultra-long-term compounding ability and core values of management integrity, employee empowerment, teamwork, passion, long-term focus, and disciplined capital allocation.
Document Source: https://www.prnewswire.com/news-releases/front-street-capital-management-selects-sei-for-custody-and-advisor-technology-302312057.html
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 7:02 p.m. / Source: PR Newswire
Activity Class: CorporateFinanceActivity
/ Type: Investment
Investor:
Target:
Document Extract: Saothair Capital Partners Completes Acquisition of Pioneer Windows.
Document Source: https://www.prnewswire.com/news-releases/saothair-capital-partners-completes-acquisition-of-pioneer-windows-302311911.html
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 7:02 p.m. / Source: PR Newswire
Activity Class: CorporateFinanceActivity
/ Type: Investment
/ Region: New York City, Metropolitan
Investor:
Target:
Document Extract: WAYNE, Pa., Nov. 20, 2024 /PRNewswire/ - Saothair Capital Partners, LLC ("Saothair") , a private equity firm focused exclusively on investing in middle-market manufacturing and industrial companies, announced it has acquired a majority equity stake in Pioneer Window Holdings, Inc. ("Pioneer") through a newly-formed affiliate.
Document Source: https://www.prnewswire.com/news-releases/saothair-capital-partners-completes-acquisition-of-pioneer-windows-302311911.html
(archive.org page /
archive.org listing)
Document Date: Nov. 18, 2024, 1:10 p.m. / Source: GlobeNewswire
Activity Class: CorporateFinanceActivity
/ Type: Investment
/ Region: United States
Investor:
Target:
- Aclaris Therapeutics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 3 more
Document Extract: WAYNE, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) - Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the "Company" or "Aclaris") , a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that it has entered into a securities purchase agreement with a group of accredited investors for the private placement of 35,555,555 shares of common stock at a purchase price of $ 2.25 per share, for gross proceeds of approximately $ 80.0 million.
Document Source: https://www.globenewswire.com/news-release/2024/11/18/2982760/37216/en/Aclaris-Therapeutics-Announces-80-Million-Private-Placement.html
(archive.org page /
archive.org listing)
Document Date: Nov. 18, 2024, 1:10 p.m. / Source: GlobeNewswire
Activity Class: PartnershipActivity
/ Region: Wayne
Partnership:
- Aclaris Therapeutics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 3 more
- Biosion
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology
- Aclaris Therapeutics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 3 more
- Biosion
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 1 more
Document Extract: WAYNE, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) - Aclaris Therapeutics, Inc. (NASDAQ: ACRS) , a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that it has entered into an exclusive license agreement with Biosion, Inc. (Biosion) for worldwide rights (excluding Greater China) to BSI-045B, a potential best-in-class, clinical-stage, novel anti-TSLP monoclonal antibody, and BSI-502, a potential best-in-class, pre-clinical stage, novel bispecific antibody that is directed against both TSLP and IL4R. " This transformative transaction, which marks the completion of our strategic review process, accelerates our evolution into becoming a leading immunology company with both small and large molecule drugs ," said Dr. Neal Walker, Interim CEO and Chair of the Board of Directors of Aclaris. " Despite recent advances with anti-TSLP and anti-IL4R therapies, there remains substantial unmet need for more effective and convenient treatment options. BSI-045B's compelling Phase 2a proof-of-concept data in atopic dermatitis, together with BSI-502's dual-targeting approach, complement our existing ITK inhibitor portfolio, resulting in a pipeline of differentiated assets that targets multiple high-value indications. In addition, the proceeds from the private placement financing announced this morning bolsters our balance sheet and provides us with enhanced financial flexibility to support our strategic growth while maintaining our cash runway into 2028 ."
Document Source: https://www.globenewswire.com/news-release/2024/11/18/2982759/37216/en/Aclaris-Therapeutics-Announces-Exclusive-Global-License-Agreement-with-Biosion-Inc-adding-Potential-Best-in-Class-Biologics-Assets-to-Pipeline.html
(archive.org page /
archive.org listing)
Document Date: Nov. 18, 2024, 1:50 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: Newark, People’s Republic of China
Partnership:
- Biosion
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology
- Aclaris Therapeutics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 3 more
- Aclaris Therapeutics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 3 more
- Biosion
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 1 more
Document Extract: cash payment as upfront license fee and reimbursement for certain development costs & drug product materials, and 19.9 % shares of common stock of Aclaris Therapeutics; additional regulatory and sales milestone payments exceed with tiered single digit sales royalty Aclaris Therapeutics will be responsible for development and commercialization of BSI-045B, a novel anti-TSLP monoclonal antibody, and BSI-502, a novel bispecific antibody that is directed against both TSLP and IL4R worldwide (excluding Greater China) NEWARK, Del. and NANJING, China, Nov. 18, 2024 /PRNewswire/ - Biosion, Inc. (Biosion) , a global R & D stage biotechnology company, today announced that it has entered into an exclusive license agreement with Aclaris Therapeutics (NASDAQ: ACRS) for worldwide rights (excluding Greater China) to BSI-045B, a potential First-in-class, clinical-stage, novel anti-TSLP monoclonal antibody, and BSI-502, a potential best-in-class, pre-clinical stage, novel bispecific antibody that is directed against both TSLP and IL4R. Under the terms of the agreement, Biosion shall receive over $ 40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materials. Biosion shall also receive 19.9 % shares of common stock of Aclaris Therapeutics.
Document Source: https://www.prnewswire.com/news-releases/biosion-announces-exclusive-global-license-agreement-with-aclaris-therapeutics-on-two-potential-first-in-class-and-best-in-class-immunology-assets-302308547.html
(archive.org page /
archive.org listing)
Document Date: Nov. 18, 2024, 2 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: County Durham, United Kingdom of Great Britain and Northern Ireland
Partnership:
- Power Roll Limited
/ Industry: Solar Technology
- Amcor
/ Industry: Medical Device And Pharmaceutical Packaging, Packaging Solutions
- Amcor
/ Industry: Medical Device And Pharmaceutical Packaging, Packaging Solutions
Document Extract: ZURICH, Nov. 18, 2024 /PRNewswire/ - Amcor (NYSE: AMCR) (ASX: AMC) , a global leader in developing and producing responsible packaging solutions, today announced it has signed a Memorandum of Understanding (MOU) with U.K. - based technology pioneers, Power Roll Limited. Amcor and Power Roll's collaboration aims to revolutionize solar-powered energy by developing a lightweight solar photovoltaic film that can deliver a low-cost alternative to silicon solar panels. Amcor announced it has signed a Memorandum of Understanding (MOU) with U.K. - based technology pioneers, Power Roll Limited. Power Roll's film material provides a lightweight and flexible solution that can be used on a variety of applications from fragile rooftops, facades, off-grid local generation and within the transport sector. Importantly, Power Roll's technology is not reliant on rare earth minerals and can be manufactured using roll-to-roll processes.
Document Source: https://www.prnewswire.com/news-releases/amcor-and-power-roll-to-deliver-revolutionary-solar-photovoltaic-film-302307830.html
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 8:26 p.m. / Source: The Globe and Mail
Activity Class: CorporateFinanceActivity
/ Type: Ipo
/ Region: United States
Vendor:
- Comcast
/ Industry: Ad Technology, Broadcast Tv, Digital Media And Radio and 6 more
Document Extract: Comcast Corp. shares moved up this week on news the U.S. conglomerate will go ahead with the US $ 7-billion spinoff of its NBCUniversal cable TV network business.
Document Source: https://www.theglobeandmail.com/investing/investment-ideas/number-cruncher/article-dividend-paying-stocks-with-upcoming-spinoffs-in-2025/
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 8:26 p.m. / Source: The Globe and Mail
Activity Class: CorporateFinanceActivity
/ Type: Ipo
/ Region: United States
Vendor:
- Comcast
/ Industry: Ad Technology, Broadcast Tv, Digital Media And Radio and 6 more
Target:
- NBCUniversal
/ Industry: Ad Technology, Broadcast Tv, Digital Media And Radio and 5 more
Document Extract: Comcast Corp. shares moved up this week on news the U.S. conglomerate will go ahead with the US $ 7-billion spinoff of its NBCUniversal cable TV network business.
Document Source: https://www.theglobeandmail.com/investing/investment-ideas/number-cruncher/article-dividend-paying-stocks-with-upcoming-spinoffs-in-2025/
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 12:30 p.m. / Source: The Globe and Mail
Activity Class: CorporateFinanceActivity
/ Type: Ipo
Vendor:
- Comcast
/ Industry: Ad Technology, Broadcast Tv, Digital Media And Radio and 6 more
Target:
- NBCUniversal
/ Industry: Ad Technology, Broadcast Tv, Digital Media And Radio and 5 more
Document Extract: Comcast CCZ-N is moving forward with plans to spin off its NBCUniversal cable television networks including MSNBC and CNBC, sources say, shedding a once core part of the business that has been a casualty of the streaming video revolution.
Document Source: https://www.theglobeandmail.com/business/international-business/article-comcast-to-proceed-with-plans-to-spin-off-its-cable-channels/
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 1 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
Partnership:
Document Extract: Business Consulting Leader (BCL) , a wholly owned subsidiary of Technology Leader Companies LLC, formalizes status with Acumatica ERP as a Services Partner. LANCASTER, Pa., Nov. 21, 2024 /PRNewswire/ - This new Services Partner designation will allow Business Consulting Leader to offer a wider array of services to Acumatica clients through the Acumatica VAR Partner channel. The consulting group, originally spun off from the Presales-as-a-Service offered by sister company Presales Leader, has grown to a point where it can deliver a robust suite of services to Acumatica end clients and partners. Jeremy Potoka, Founder and Principal Solutions Architect shared his excitement about formalizing this relationship with Acumatica. " We 've been offering consulting services post-sale for over two years and took time to carefully build our team to fully support clients post-sale.
Document Source: https://www.prnewswire.com/news-releases/business-consulting-leader-llc-joins-acumaticas-services-partner-program-302312844.html
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 3 p.m. / Source: Business Wire
Activity Class: CorporateFinanceActivity
/ Type: Investment
Investor:
Target:
- Enveda
/ Industry: Biotech And Technology, Drug Development And Discovery
Document Extract: Enveda, a biotechnology company using AI to translate nature into new medicines, announced today an oversubscribed $ 130 million Series C funding round led by Kinnevik and FPV with participation from new and existing investors Baillie Gifford, Premji Invest, Lingotto Innovation, Lux Capital, Dimension Capital, True Ventures, Cresset Partners, The Nature Conservancy, and Henry R. Kravis.
Document Source: https://www.businesswire.com/news/home/20241121310215/en/Enveda-Closes-130M-Series-C-Funding-to-Deliver-Multiple-Clinical-Readouts-from-a-Pipeline-of-10-Development-Candidates
(archive.org page /
archive.org listing)
Document Date: Nov. 19, 2024, 1:30 p.m. / Source: GlobeNewswire
Activity Class: CorporateFinanceActivity
/ Type: Investment
Target:
- Genie Energy Ltd.
/ Industry: Energy And Technology, Energy Trading And Market Risk Management and 3 more
Document Extract: NEWARK, NJ, Nov. 19, 2024 (GLOBE NEWSWIRE) - Genie Energy Ltd., (NYSE: GNE) , a retail energy and renewable energy solutions provider, today announced that it has closed on a loan financing on a portfolio of operating solar generation assets.
Document Source: https://www.globenewswire.com/news-release/2024/11/19/2983607/0/en/Genie-Energy-Closes-on-Solar-Generation-Project-Financing.html
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 2:58 p.m. / Source: Associated Press
Activity Class: RoleActivity
/ Type: Starting
/ Region: Pittsburgh
Role:
Person:
Organization:
Document Extract: The Pittsburgh Pirates have hired Matt Hague as their hitting coach, bringing him back to the team that drafted him in 2008.
Document Source: https://apnews.com/article/pittsburgh-pirates-mlb-06659f52810e0e322c7a1ff97368b2cc
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 2:30 p.m. / Source: GlobeNewswire
Activity Class: RoleActivity
/ Type: Starting
/ Region: York
Role:
Person:
Organization:
- WellSpan Health
/ Industry: Health, And Wellness, Hospital Management Service
- WellSpan Health
/ Industry: Health, And Wellness, Hospital Management Service
Document Extract: York, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) - As the region's leading locally governed nonprofit health system, WellSpan Health has promoted two leaders into key systemwide executive roles.
Document Source: https://www.globenewswire.com/news-release/2024/11/20/2984542/0/en/WellSpan-names-chief-operating-officer-and-chief-strategy-officer-for-the-health-system.html
(archive.org page /
archive.org listing)
Archive.org page links will work if the page has already been archived by archive.org, but we can't guarantee which pages archive.org has archived so far.
Treat sameAsNameOnly relationship as same? Yes
(Turn Off)
Site Stats
| About (includes privacy and cookie notices)
(c) by 1145, 2023-2024. Data licensed under the Open Database License.
Please send an email if you need a non-share-alike license and/or you need API access.